Entity Common Stock, Shares Outstanding of ARROWHEAD PHARMACEUTICALS, INC. from 01 Aug 2011 to 30 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 30 Jan 2026.
  • ARROWHEAD PHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 30 Jan 2026 was 140,032,190, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 140,032,190 +13,934,079 +11% 30 Jan 2026 10-Q 05 Feb 2026 2026 Q1
Q4 2025 135,809,558 +9,711,447 +7.7% 19 Nov 2025 10-K 25 Nov 2025 2025 FY
Q2 2025 138,257,550 +13,942,276 +11% 01 Aug 2025 10-Q 07 Aug 2025 2025 Q3
Q1 2025 138,100,435 +13,900,205 +11% 01 May 2025 10-Q 12 May 2025 2025 Q2
Q4 2024 126,098,111 +2,201,197 +1.8% 03 Feb 2025 10-Q 10 Feb 2025 2025 Q1
Q2 2024 124,315,274 +17,122,373 +16% 01 Aug 2024 10-Q 08 Aug 2024 2024 Q3
Q1 2024 124,200,230 +17,299,809 +16% 01 May 2024 10-Q 09 May 2024 2024 Q2
Q4 2023 123,896,914 +15,586,751 +14% 31 Jan 2024 10-Q 06 Feb 2024 2024 Q1
Q2 2023 107,192,901 +1,343,938 +1.3% 31 Jul 2023 10-Q 07 Aug 2023 2023 Q3
Q1 2023 106,900,421 +1,164,221 +1.1% 24 Apr 2023 10-Q 02 May 2023 2023 Q2
Q4 2022 108,310,163 +2,850,447 +2.7% 01 Feb 2023 10-Q 06 Feb 2023 2023 Q1
Q2 2022 105,848,963 +1,589,707 +1.5% 28 Jul 2022 10-Q 04 Aug 2022 2022 Q3
Q1 2022 105,736,200 +1,651,324 +1.6% 05 May 2022 10-Q 10 May 2022 2022 Q2
Q4 2021 105,459,716 +1,667,306 +1.6% 31 Jan 2022 10-Q 02 Feb 2022 2022 Q1
Q2 2021 104,259,256 +1,967,453 +1.9% 02 Aug 2021 10-Q 05 Aug 2021 2021 Q3
Q1 2021 104,084,876 +2,311,602 +2.3% 30 Apr 2021 10-Q 04 May 2021 2021 Q2
Q4 2020 103,792,410 +2,137,933 +2.1% 01 Feb 2021 10-Q 04 Feb 2021 2021 Q1
Q2 2020 102,291,803 +6,990,811 +7.3% 27 Jul 2020 10-Q 05 Aug 2020 2020 Q3
Q1 2020 101,773,274 +6,959,188 +7.3% 05 May 2020 10-Q 07 May 2020 2020 Q2
Q4 2019 101,654,477 +9,429,812 +10% 03 Feb 2020 10-Q 05 Feb 2020 2020 Q1
Q2 2019 95,300,992 +7,277,843 +8.3% 02 Aug 2019 10-Q 05 Aug 2019 2019 Q3
Q1 2019 94,814,086 +7,236,898 +8.3% 06 May 2019 10-Q 08 May 2019 2019 Q2
Q4 2018 92,224,665 +17,396,385 +23% 07 Dec 2018 10-K 11 Dec 2018 2018 FY
Q2 2018 88,023,149 +13,251,046 +18% 06 Aug 2018 10-Q 07 Aug 2018 2018 Q3
Q1 2018 87,577,188 +12,805,085 +17% 07 May 2018 10-Q 08 May 2018 2018 Q2
Q4 2017 74,828,280 +654,796 +0.88% 06 Dec 2017 10-K 12 Dec 2017 2017 FY
Q2 2017 74,772,103 +14,021,776 +23% 01 Aug 2017 10-Q 03 Aug 2017 2017 Q3
Q1 2017 74,772,103 +14,811,392 +25% 02 May 2017 10-Q 03 May 2017 2017 Q2
Q4 2016 74,173,484 +14,618,807 +25% 12 Dec 2016 10-K 14 Dec 2016 2016 FY
Q2 2016 60,750,327 +1,249,465 +2.1% 08 Aug 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 59,960,711 +462,349 +0.78% 09 May 2016 10-Q 10 May 2016 2016 Q2
Q4 2015 59,554,677 +4,762,028 +8.7% 11 Dec 2015 10-K 14 Dec 2015 2015 FY
Q2 2015 59,500,862 +6,592,295 +12% 31 Jul 2015 10-Q 04 Aug 2015 2015 Q3
Q1 2015 59,498,362 +7,625,991 +15% 08 May 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 54,792,649 +16,092,286 +42% 05 Feb 2015 10-Q 09 Feb 2015 2015 Q1
Q2 2014 52,908,567 +21,369,368 +68% 11 Aug 2014 10-Q 12 Aug 2014 2014 Q3
Q1 2014 51,872,371 +20,567,054 +66% 01 May 2014 10-Q 06 May 2014 2014 Q2
Q4 2013 38,700,363 +23,056,205 +147% 16 Dec 2013 10-K 18 Dec 2013 2013 FY
Q2 2013 31,539,199 +20,228,383 +179% 05 Aug 2013 10-Q 07 Aug 2013 2013 Q3
Q1 2013 31,305,317 +20,092,322 +179% 07 May 2013 10-Q 09 May 2013 2013 Q2
Q4 2012 15,644,158 +5,118,217 +49% 21 Dec 2012 10-K 28 Dec 2012 2012 FY
Q2 2012 11,310,816 -60,522,877 -84% 03 Aug 2012 10-Q 13 Aug 2012 2012 Q3
Q1 2012 11,212,995 01 May 2012 10-Q 08 May 2012 2012 Q2
Q4 2011 10,525,941 15 Dec 2011 10-K 20 Dec 2011 2011 FY
Q2 2011 71,833,693 01 Aug 2011 10-Q 08 Aug 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.